Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2809–2832 of 79,410 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: 2 Clear all

Conditions: Cervical Dystonia
Interventions: Botulinum toxin type A; Biological
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 41
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 34 more

Conditions: Cancer
Interventions: Waitlist control, 3RP-AYA; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 16 Years to 29 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Emergency Department Patient, QTc Intervals Changes
Interventions: Droperidol injection; Drug
Lead sponsor: CHRISTUS Health; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Stroke, Cerebral Ischemia, Brain Infarction
Interventions: Ancrod (Viprinex), Placebo; Drug
Lead sponsor: Neurobiological Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 277 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 58
States / cities: Phoenix, Arizona • Fort Smith, Arkansas • Loma Linda, California + 48 more

Conditions: Smoking Cessation, Cancer, Treatment-Related
Interventions: Varenicline, Bupropion, Long-acting nicotine replacement therapy, Low-intensity counseling, High-intensity counseling, No nicotine replacement therapy, Nicotine Replacement Products; Drug · Behavioral · Other
Lead sponsor: Joseph Valentino, MD; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Bowling Green, Kentucky • Lexington, Kentucky • Owensboro, Kentucky

Conditions: Smoking, Stress
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 25 Years to 55 Years
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Metastatic Breast Cancer
Interventions: Sorafenib, Ixabepilone; Drug
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 15
States / cities: Fort Myers, Florida • Terre Haute, Indiana • Louisville, Kentucky + 10 more

Conditions: High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma
Interventions: Regadenoson 0.05mg, Regadensoson 0.1mg, Regadensoson 0.2mg, Regadensoson 0.4mg, Regadensoson 0.7mg, Regadensoson 1.0mg, Regadensoson 1.4mg; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 45 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Baltimore, Maryland • Winston-Salem, North Carolina

Conditions: Bone Metastases, Lymphoma, Multiple Myeloma, Opioid Use, Pain
Interventions: Ketorolac, Normal saline, Acetaminophen, Oxycodone Acetaminophen, Morphine, Hydrocodone/Acetaminophen, Oxycodone; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obsessive-Compulsive Disorder
Interventions: Summit RC+S System, One Month Blinded Discontinuation Period:; Device · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 21 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania • Providence, Rhode Island • Houston, Texas

Conditions: Bioavailability of Carotenoids
Interventions: Pink grapefruit first followed by tangerines two weeks later, Tangerines first followed by pink grapefruit two weeks later; Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Davis, California

Conditions: Insulin Resistance
Interventions: Exercise; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 30 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Continuous Local Infiltration Analgesia, Intra-articular Catheter, Total Knee Arthroplasty
Interventions: Intra-articular catheter, Routine Standard of Care Treatment; Device · Other
Lead sponsor: OrthoCarolina Research Institute, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Rectal Neoplasms
Interventions: FOLFOX, total mesorectal excision (TME); Drug · Procedure
Lead sponsor: Beth Israel Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: New York, New York

Conditions: Smoldering Multiple Myeloma
Interventions: PVX-410; Biological
Lead sponsor: OncoPep, Inc.; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 6
States / cities: Atlanta, Georgia • Niles, Illinois • Boston, Massachusetts + 1 more

Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Interventions: Exercise Intervention, Questionnaire Administration; Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Cystic Fibrosis
Interventions: Tobramycin Inhalation Powder; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 6 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 21
States / cities: Mobile, Alabama • Los Angeles, California • Sacramento, California + 18 more

Conditions: Type 1 Diabetes
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: AL Amyloidosis
Interventions: Pomalidomide, Dexamethasone; Drug
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Low Back Pain
Interventions: ABT-712, Placebo; Drug
Lead sponsor: AbbVie (prior sponsor, Abbott); Industry
Eligibility: 21 Years to 75 Years
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 31
States / cities: Huntsville, Alabama • Burbank, California • San Diego, California + 27 more

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma
Interventions: Cytoreductive Surgery (CRS), Adjuvant Chemotherapy, Questionnaire, Hyperthermic intraperitoneal chemotherapy, Carboplatin, Paclitaxel, Cisplatin; Procedure · Drug · Other
Lead sponsor: Mercy Medical Center; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pediatric Obesity, Type 2 Diabetes, Metabolic Syndrome
Interventions: Family Focused Lifestyle Intervention; Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 8 Years to 11 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Sarcopenia
Interventions: Recommended Dietary Allowance of Protein, Habitual protein intake, Optimal Protein Intake; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 50 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Osteoporosis
Interventions: placebo, risedronate; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 40 Years to 57 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 3
States / cities: Tuscon, Arizona • Omaha, Nebraska • Cincinnati, Ohio

Search by objective public record fields.

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

Droperidol and QTc Interval Changes in ED Patients

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment

Physiological Responses in Tobacco Chippers

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

Development of Adaptive Deep Brain Stimulation for OCD

Human Lycopene and Beta-cryptoxanthin Absorption From Citrus Fruit

Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals With Insulin Resistance

Intra-Articular Catheter Total Knee Arthroplasty

Neo-Adjuvant FOLFOX for Rectal Carcinoma

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles

Skeletal Muscle Health in Children With Type 1 Diabetes

A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

HOT: HIPEC in Ovarian Cancer as Initial Treatment

A Family Based Intervention to Reduce the Risk of Type 2 Diabetes in Children

Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics

Bone Microarchitecture in Osteopenic Postmenopausal Women